drugset / Trial / NCT06434350
Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)
NaSingle-groupOpen-labelTreatment
Summary
To learn if the combination of enfortumab vedotin plus radiation therapy could help to control the disease.
Timeline
- Start
- 2024-10-10
- Primary completion
- 2027-09-24
- Completion
- 2027-09-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enfortumab Vedotin | Other / unclassified | — | Intravenous |